...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers
【24h】

Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers

机译:分泌型白细胞蛋白酶抑制剂抑制人免疫缺陷病毒1型感染单核细胞和淋巴细胞,但不会干扰紧密结合的上皮屏障的细胞相关病毒的转胞作用

获取原文
           

摘要

In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immunodeficiency virus type 1 (HIV-1). In contrast, rhSLPI did not exhibit inhibitory activity toward transcytosis of cell-associated HIV-1 through a tight monolayer of endometrial epithelial cells. These observations indicate that the inhibitory effect of SLPI is restricted to free HIV-1 in corporal fluids.
机译:在本研究中,我们证明了重组人分泌型白细胞蛋白酶抑制剂(rhSLPI)可以抑制淋巴细胞和单核细胞衍生的肿瘤细胞系和外周血淋巴细胞感染,其具有实验室适应性分离株和游离人免疫缺陷的主要分离株NDK。 1型病毒(HIV-1)。相反,rhSLPI没有通过紧密的单层子宫内膜上皮细胞对细胞相关HIV-1的胞吞作用表现出抑制活性。这些观察结果表明SLPI的抑制作用限于体液中的游离HIV-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号